Common blood pressure pill tested in bold new strategy to lock away HIV
NCT ID NCT07415811
Summary
This study is testing if spironolactone, an existing blood pressure medication, can help control HIV by silencing the virus that hides in the body. It will enroll 12 adults, including some without HIV and some with well-controlled HIV on medication. Researchers will see if the drug safely degrades a specific human protein that HIV needs, aiming to 'lock' the hidden virus in a dormant state.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Grupo de Pesquisa Clínica em Moléstias Infecciosas
São Paulo, São Paulo, 05401000, Brazil
Conditions
Explore the condition pages connected to this study.